NAD Repletion Therapy: A Silver Bullet for HFpEF?

Circ Res. 2021 May 28;128(11):1642-1645. doi: 10.1161/CIRCRESAHA.121.319308. Epub 2021 May 27.

Authors

Fadi G Akar^{1

2}, Lawrence H Young^{1

3}

Affiliations

¹ Internal Medicine (Cardiovascular) (F.G.A., L.H.Y.), Yale School of Medicine, New Haven, CT.
² Department of Biomedical Engineering (F.G.A.), Yale School of Medicine, New Haven, CT.
³ Cellular & Molecular Physiology (LH.Y.), Yale School of Medicine, New Haven, CT.

No abstract available

Keywords: Editorials; heart failure; metabolism; mitochondria; obesity.

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Heart Failure* / drug therapy
Humans
NAD
Obesity
Stroke Volume

Substances

NAD

Grants and funding